Caris Life Sciences, Inc.

General ticker "CAI" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $7.1B (TTM average)

Caris Life Sciences, Inc. follows the US Stock Market performance with the rate: 29.1%.

Estimated limits based on current volatility of 4.0%: low 19.93$, high 21.60$

Factors to consider:

  • Total employees count: 1846 as of 2025
  • US accounted for 98.7% of revenue in the fiscal year ended 2025-12-31
  • Top business risk factors: Market competition, Operational and conduct risks, Reimbursement changes, Regulatory and compliance, Capital access

Similar symbols

Short-term CAI quotes

Long-term CAI plot

Financial data

YTD 2025-12-31
Operating Revenue $812.03MM
Operating Expenses $766.92MM
Operating Income $45.11MM
Non-Operating Income $-113.20MM
Interest Expense $56.85MM
R&D Expense $45.31MM
Income(Loss) $-68.09MM
Net Income(Loss)* $-537.96MM
Stockholders Equity $577.31MM
Assets $1,125.66MM
Operating Cash Flow $83.16MM
Capital expenditure $16.26MM
Investing Cash Flow $-16.26MM
Financing Cash Flow $664.99MM
Earnings Per Share** $-3.22

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.